Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
ES07 - Thoracic Ultrasonography: Diagnosis and Staging
- 13:30 - 15:00
- 9/08/2019
- Location: San Francisco (2009)
- IASLC CME Accredited
- Type: Educational Session
- Track: Interventional Diagnostics/Pulmonology
- Moderators:Felipe Andreo, Bin Hwangbo
-
+
Introduction/Poll
13:30 - 13:30
- Abstract
No abstract available for this presentation
-
+
ES07.01 - Transthoracic Ultrasonography
13:30 - 13:50 | Presenter: Najib M Rahman
- Abstract
Loading... -
+
ES07.02 - Linear Endosonography (EBUS & EUS)
13:50 - 14:10 | Presenter: Laurence M.M.J Crombag
- Abstract
No abstract available for this presentation
-
+
ES07.03 - Radial Endosonography
14:10 - 14:30 | Presenter: Laurence M.M.J Crombag
- Abstract
Loading... -
+
ES07.04 - Predictive Molecular Testing on Small Biopsy Samples
14:30 - 14:50 | Presenter: Christophe Dooms
- Abstract
Loading... -
+
ES07.05 - Q&A/Poll
14:50 - 15:00
- Abstract
No abstract available for this presentation
-
+
ES08 - Critical Concerns in Screening
- 13:30 - 15:00
- 9/08/2019
- Location: Copenhagen (1980)
- IASLC CME Accredited
- Type: Educational Session
- Track: Screening and Early Detection
- Moderators:Ugo Pastorino, John Kirkpatrick Field
-
+
Introduction/Poll
13:30 - 13:30
- Abstract
No abstract available for this presentation
-
+
ES08.01 - Participation of the Target Population in Lung Cancer Screening
13:30 - 13:40 | Presenter: Robin Cornelissen
- Abstract
Loading... -
+
ES08.02 - Nodule Growth Assessment
13:40 - 13:50 | Presenter: Matthijs Oudkerk
- Abstract
Loading... -
+
ES08.03 - The Magnitude of the Benefit
13:50 - 14:00 | Presenter: David F. Yankelevitz
- Abstract
Loading... -
+
ES08.04 - Management Algorithms
14:00 - 14:10 | Presenter: Claudia I Henschke | Author(s): Rowena Yip, Teng Ma, Samuel Miguel Aguayo, Javier Zulueta, David Yankelevitz
- Abstract
Loading... -
+
ES08.05 - Advances in Artificial Intelligence - How Lung Cancer CT Screening Will Progress?
14:10 - 14:20 | Presenter: Debora Gil | Author(s): Antoni Rosell
- Abstract
Loading... -
+
ES08.06 - Cost Effectiveness of Comprehensive Screening and Smoking Cessation Programmes
14:20 - 14:30 | Presenter: Bruce Pyenson
- Abstract
Loading... -
+
ES08.07 - System Approach to Screening Management
14:30 - 14:40 | Presenter: Anthony P Reeves
- Abstract
Loading... -
+
ES08.08 - Q&A/Poll
14:40 - 15:00
- Abstract
No abstract available for this presentation
-
+
ES09 - How I Do It - Real World Issues in the Diagnosis and Treatment of Metastatic NSCLC
- 13:30 - 15:00
- 9/08/2019
- Location: Tokyo (1982)
- IASLC CME Accredited
- Type: Educational Session
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
- Moderators:Margarida Dias, David Dawe, Carlos Cabrera
-
+
ES09.01 - How I Optimize Tissue Specimen Processing for Histopathological and Molecular Profiling
13:30 - 13:45 | Presenter: Amanjit Bal
- Abstract
Loading... -
+
ES09.02 - How I Report Imaging for Assessment of Responses to Targeted Therapies vs. Immune Checkpoint Inhibitors vs. Chemotherapy
13:45 - 14:00 | Presenter: Ritu R Gill
- Abstract
Loading... -
+
ES09.03 - How I Decide 1st Line Treatment Options for Metastatic NSCLC Without Driver Mutations - Balancing Efficacy, Toxicity and Cost
14:00 - 14:15 | Presenter: Martin NA Frueh
- Abstract
Loading... -
+
ES09.04 - How I Decide 2nd Line Treatment Options for Relapsed/Refractory Metastatic NSCLC
14:15 - 14:30 | Presenter: Navneet Singh
- Abstract
Loading... -
+
ES09.05 - Limitations in the Availability of Radiotherapy
14:30 - 14:45 | Presenter: Jamal Saleh Khader
- Abstract
Loading... -
+
ES09.06 - Q&A
14:45 - 15:00
- Abstract
No abstract available for this presentation
-
+
ES10 - Oncology Drug Approval: Challenges and Opportunities
- 13:30 - 15:00
- 9/08/2019
- Location: Toronto (1985)
- IASLC CME Accredited
- Type: Educational Session
- Track: Advanced NSCLC
- Moderators:Caicun Zhou, Alice T. Shaw
-
+
ES10.01 - US Food and Drug Administration
13:30 - 13:45 | Presenter: Gideon M Blumenthal
- Abstract
Loading... -
+
ES10.02 - Japan Pharmaceuticals and Medical Devices Agency
13:45 - 14:00 | Presenter: Sumimasa Nagai
- Abstract
Loading... -
+
ES10.03 - China National Medical Products Administration (Formerly CFDA)
14:00 - 14:15 | Presenter: Tony Mok
- Abstract
No abstract available for this presentation
-
+
ES10.04 - European Medicines Agency
14:15 - 14:30 | Presenter: Jorge Camarero
- Abstract
Loading... -
+
ES10.05 - Brazilian Health Regulatory Agency - Agência Nacional de Vigilância Sanitária
14:30 - 14:45 | Presenter: Carlos Gil Ferreira
- Abstract
Loading... -
+
ES10.06 - Q&A
14:45 - 15:00
- Abstract
No abstract available for this presentation
-
+
GR01 - Whether and How to Adapt Treatment of NSCLC Oligometastatic Disease to…
- 13:30 - 15:00
- 9/08/2019
- Location: Seoul (2007)
- IASLC CME Accredited
- Type: Grand Rounds Session
- Track: Oligometastatic NSCLC
- Moderators:Jin-Soo Lee, Laurie Gaspar
-
+
GR01.01 - Definition and Minimal Staging in Oligometastatic Disease
13:30 - 13:45 | Presenter: Anne Marie Clasina Dingemans
- Abstract
Loading... -
+
GR01.02 - Local Stage of the Primary Disease?
13:45 - 14:00 | Presenter: Valerie W. Rusch
- Abstract
No abstract available for this presentation
-
+
GR01.03 - Nodal Status of the Primary Disease?
14:00 - 14:15 | Presenter: David Ball
- Abstract
Loading... -
+
GR01.04 - The Rationale for Local Consolidative Therapy in Oncogene-driven, Oligo-and Poly-metastatic NSCLC
14:15 - 14:30 | Presenter: John Victor Heymach
- Abstract
No abstract available for this presentation
-
+
GR01.05 - Site of Oligometastases
14:30 - 14:45 | Presenter: Paul Van Schil
- Abstract
Loading... -
+
GR01.06 - Q&A
14:45 - 15:00
- Abstract
No abstract available for this presentation
-
+
MA04 - Models and Biomarkers
- 13:30 - 15:00
- 9/08/2019
- Location: Interlaken (1988)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Biology
- Moderators:Montse Sanchez-Cespedes, Kwok-kin Wong
-
+
MA04.01 - Development of an in Vivo Platform to Identify Novel Mechanisms Governing Lung Cancer Response to Immunotherapy
13:30 - 13:35 | Presenter: Kelsie L Thu | Author(s): Shawn P Kubli, Andrew C Wakeham, Andrew J Elia, Tak Mak
- Abstract
Loading... -
+
MA04.02 - Molecular Profiling of Adenocarcinoma and Squamous Cell Lung Cancer at Single Cell Resolution
13:35 - 13:40 | Presenter: fengying Wu | Author(s): Yayi He, Zhou Yiqi, Anwen Xiong, Jia Yu, Wei Li, Nan Fang, Caicun Zhou
- Abstract
Loading... -
+
MA04.03 - Lung Tumorspheres Characterization Reveals Cancer Stem-Like Cells Potential Targets and Prognostic Markers in Non-Small Cell Lung Cancer
13:40 - 13:45 | Presenter: Alejandro Herreros-Pomares | Author(s): Eloisa Jantus-Lewintre, Silvia Calabuig-Fariñas, Juan Diego De-Maya-Girones, Rut Lucas, Ana Blasco, Ricardo Guijarro, Miguel Martorell, Eva Escorihuela, María Dolores Chiara, Elena Durendez-Saez, Carolina Gandia, Rafael Sirera, Rosa Farràs, Carlos Camps
- Abstract
Loading... -
+
MA04.04 - Discussant - MA04.01, MA04.02, MA04.03
13:45 - 14:00 | Presenter: David Santamaria
- Abstract
No abstract available for this presentation
-
+
MA04.05 - Deciphering the Molecular Mechanisms Underlying the Progression of Bronchial Premalignant Lesions
14:00 - 14:05 | Presenter: Evgeny V. Denisov | Author(s): Polina A. Gervas, Anastasia A. Ponomaryova, Anastasia A. Schegoleva, Tatiana S. Gerashchenko, Artem M. Kiselev, German M. Demidov, Alexey A. Zarubin, Liliya S. Lyapunova, Sergey P. Kovalenko, Olga V. Cheremisina, Sergey A. Tuzikov, Olga V. Pankova, Nadezhda V. Cherdyntseva, Vladimir M. Perelmuter
- Abstract
Loading... -
+
MA04.06 - Lung Epithelium Whole Transcriptome Signatures That Reflect Incident Lung Cancer Case-Control Status
14:05 - 14:10 | Presenter: Simon D Spivack | Author(s): Xiao Dong, Miao Kevin Shi, Weiguo Han, Steven Keller, Alex Maslov, Yousin Suh, Jan Vijg
- Abstract
Loading... -
+
MA04.07 - Inhibition of CXCR2+ Neutrophil Migration as a Targeted Therapy in KRAS-Driven Lung Adenocarcinoma
14:10 - 14:15 | Presenter: Meghan De Meo | Author(s): Roni F. Rayes, Simon Milette, Mara Vagai, Mariana Usatii, Arvind Chandrasekaran, Betty Giannias, France Bourdeau, Christopher Moraes, Sidong Huang, Daniela Quail, Logan Walsh, Veena Sangwan, Nicholas Bertos, Sophie Camilleri-Broet, Philippe Broet, Pierre O Fiset, Jonathan Cools-Lartigue, Lorenzo E. Ferri, Jonathan D. Spicer
- Abstract
Loading... -
+
MA04.08 - Discussant - MA04.05, MA04.06, MA04.07
14:15 - 14:30 | Presenter: Triantafillos (Lakis) Liloglou
- Abstract
No abstract available for this presentation
-
+
MA04.09 - Study of Exosomes in NSCLC for Biomarkers Searching
14:30 - 14:35 | Presenter: Elena Durendez-Saez | Author(s): Silvia Calabuig-Fariñas, Cristian Suarez, Marais Mosqueda, Sandra Gallach, Eva Escorihuela, Andrea Moreno, Susana Torres, Alejandro Herreros-Pomares, Álvaro González, Ernesto De La Cueva, Eva Serna, Jesus M Paramio, Eloisa Jantus-Lewintre, Carlos Camps
- Abstract
Loading... -
+
MA04.10 - Development and Validation of a Gene Expression-Based Prognostic Signature in Early-Stage Squamous Cell Carcinoma of the Lung
14:35 - 14:40 | Presenter: Pinaki Bose | Author(s): Anthony Boylos, Lars Frederick Petersen, Olga Kovalchuk, Igor Kovalchuk, Michelle L Dean, Doha Itani, Karen Kopciuk, Gwyn Bebb
- Abstract
Loading... -
+
MA04.11 - Biological and Prognostic Implications of the Long Non-Coding Transcriptome in Tumour-Infiltrating Immune Cells
14:40 - 14:45 | Presenter: Kevin W Ng | Author(s): Adam Sage, Erin A Marshall, Katey SS Enfield, Wan Lam
- Abstract
Loading... -
+
MA04.12 - Discussant - MA04.09, MA04.10, MA04.11
14:45 - 15:00 | Presenter: Alfonso Calvo
- Abstract
No abstract available for this presentation
-
+
MA05 - Update on Clinical Trials and Treatments
- 13:30 - 15:00
- 9/08/2019
- Location: Melbourne (1991)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Mesothelioma
- Moderators:Seiki Hasegawa, Enrico Ruffini, Angel Artal
-
+
MA05.01 - Second or Third Line Anti-PD-1 Therapy After Multimodality Therapy Including Total Pleurectomy in Malignant Pleural Mesothelioma
13:30 - 13:35 | Presenter: loic Lang-Lazdunski | Author(s): Yu Zhi Zhang, Sanjay Popat, Mary O'Brien, Jeremy Steele, Tom Newsom-Davis, Arnaud Scherpereel, Hasna Bouchaab, Alexandra Rice, Andrew G Nicholson
- Abstract
Loading... -
+
MA05.02 - Log Odds of Positive Lymph Nodes Predicts Overall Survival and the Benefit of Postoperative Radiotherapy in Malignant Pleural Mesothelioma
13:35 - 13:40 | Presenter: Yang Wo | Author(s): Yuanyong Wang, Tong Lu, Wenjie Jiao
- Abstract
Loading... -
+
MA05.03 - Impact of Time to Surgery on Outcomes in Patients Undergoing Outright Resection for Malignant Pleural Mesothelioma
13:40 - 13:45 | Presenter: Chi-Fu Jeffrey Jeffrey Yang | Author(s): Soraya Voigt, Vignesh Raman, Oliver K Jawitz, Thomas A D’amico, David Harpole
- Abstract
Loading... -
+
MA05.04 - Discussant - MA05.01, MA05.02, MA05.03
13:45 - 14:00 | Presenter: Clarissa Baldotto | Author(s):
- Abstract
No abstract available for this presentation
-
+
MA05.05 - Post-Discontinuation Treatments in IFCT-GFPC-0701 MAPS Trial: Real-World Effectiveness of 2nd-Line (2L) Treatments for Mesothelioma
14:00 - 14:05 | Presenter: Gerard Zalcman | Author(s): Solene Brosseau, Julien Mazieres, Jacques Margery, Laurent Greillier, Clarisse Audigier-Valette, Denis Moro-Sibilot, Olivier Molinier, Romain Corre, Isabelle Monnet, Valérie Gounant, Frédéric Rivière, Radj Gervais, Henri Janicot, Chrystele Locher, Alexandra Langlais, Jean-Jacques Parienti, Franck Morin, Arnaud Scherpereel
- Abstract
Loading... -
+
MA05.07 - Efficacy and Safety of Re-Treatment with Tremelimumab and Durvalumab Within the NIBIT-MESO-1 Study
14:05 - 14:10 | Presenter: Luana Calabro' | Author(s): Giulia Rossi, ALDO Morra, Anna Maria Di Giacomo, Giovanni Amato, Claudio Rosati, Ornella Cutaia, Maria Grazia Daffinà, Diana Giannarelli, MICHELE Maio
- Abstract
Loading... -
+
MA05.08 - Discussant - MA05.05, MA05.06, MA05.07
14:10 - 14:25 | Presenter: James Spicer
- Abstract
No abstract available for this presentation
-
+
MA05.09 - Real-World Data of Nivolumab and Pembrolizumab in Chemotherapy Pre-Treated Mesothelioma Patients
14:25 - 14:30 | Presenter: Daphne Dumoulin | Author(s): Luca Cantini, Robert anton Belderbos, Darlene Mercieca, Robin Cornelissen, Joachim G.J.V. Aerts
- Abstract
Loading... -
+
MA05.10 - Pembrolizumab in the Treatment of Patients with Malignant Pleural Mesothelioma Following Progression After Initial Chemotherapy
14:30 - 14:35 | Presenter: Keith Cengel | Author(s): Sharyn I Katz, Leonid Roshkovan, Sally McNulty, Jinjiang Lian, Daniel Aleynick, Melissa Jane Culligan, Joseph Friedberg, Sunil Singhal, Charles B. Simone, Li, Christine Ciunci, Melina E Marmarelis, Evan Alley, Corey Jay Langer
- Abstract
Loading... -
+
MA05.11 - Safety and Efficacy of Nintedanib in Combination with Pembrolizumab in Patients with Refractory/Relapsing Malignant Pleural Mesothelioma
14:35 - 14:40 | Presenter: Andreea Varga | Author(s): Gerard Zalcman, Carlos Gomez-Roca, Samy Ammari, CAROLINE Caramella, Valérie Gounant, Audrey Rabeau, Xavier Paoletti, Capucine Baldini, Patricia Martin-Romano, Stephane Champiat, Perrine Vuagnat, Jean-Marie Michot, Laura Mezquita, Christophe Massard, Benjamin Besse, Jean Charles Soria, Aurelien Marabelle, David Planchard
- Abstract
Loading... -
+
MA05.12 - Discussant - MA05.09, MA05.10, MA05.11
14:40 - 14:55 | Presenter: Anna K Nowak
- Abstract
No abstract available for this presentation
-
+
MA05.13 - Q&A
14:55 - 15:00
- Abstract
No abstract available for this presentation
-
+
MA06 - Challenges in the Treatment of Early Stage NSCLC
- 13:30 - 15:00
- 9/08/2019
- Location: Colorado Springs (1994)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Treatment of Early Stage/Localized Disease
- Moderators:Florentino Hernando-Trancho, Ayten Kayi Cangir
-
+
MA06.01 - Mediastinal Lymph Node Dissection (MLND) v Systematic Sampling (SS) v Neither (NN) in Population-Based Cohort
13:30 - 13:35 | Presenter: Meredith Ray | Author(s): Nicholas Faris, Carrie Fehnel, Cheryl Houston-Harris, Olawale Akinbobola, Philip Ojeabulu, Matthew P Smeltzer, Ray Osarogiagbon
- Abstract
Loading... -
+
MA06.02 - NSCLC Surgery Outcomes Between Facility Types and Association with Guideline Directed Surgical Quality of Care Metrics
13:35 - 13:40 | Presenter: David E. Gerber | Author(s): Mitchell Von Itzstein, Rong Lu, Yang Xie
- Abstract
Loading... -
+
MA06.03 - Poor Pulmonary Function Does Not Define “Medical Inoperability”: Short and Long Term Results of a Matched Lung Cancer Cohort
13:40 - 13:45 | Presenter: Brendon M Stiles | Author(s): Adam N Sholi, Mohamed K Kamel, Abu Nasar, Ajita Naik, Sebron Harrison, Benjamin Lee, Jeffrey L Port, Nasser K Altorki
- Abstract
Loading... -
+
MA06.04 - Discussant - MA06.01, MA06.02, MA06.03
13:45 - 13:55 | Presenter: Daniel J Boffa
- Abstract
No abstract available for this presentation
-
+
MA06.05 - Predictive Performance of Quantitative Metabolic Metrics of FDG-PET/CT on Survival and the Effect of Adjuvant Chemotherapy in Lung Cancer
13:55 - 14:00 | Presenter: Yojiro Makino | Author(s): Yoshihisa Shimada, Sachio Maehara, Hagiwara Masaru, Masatoshi Kakihana, Naohiro Kajiwara, Tatsuo Ohira, Norihiko Ikeda
- Abstract
Loading... -
+
MA06.06 - A Phase III Study of Adjuvant Chemotherapy in Patients with Completely Resected, Node-Negative Non-Small Cell Lung Cancer
14:00 - 14:05 | Presenter: Hideo Kunitoh | Author(s): Hiroyuki Sakurai, Masahiro Tsuboi, Masashi Wakabayashi, Morihito Okada, Kenji Suzuki, Norihiko Ikeda, Makoto Takahama, Mitsuhiro Takenoyama, Yasuhisa Ohde, Katsuo Yoshiya, Isao Matsumoto, Motohiro Yamashita, Takashi Marutsuka, Hiroshi Date, Toru Hasumi, Yoshinori Yamashita, Norihito Okumura, Shun-ichi Watanabe, Hisao Asamura
- Abstract
Loading... -
+
MA06.07 - E1505: Adjuvant Chemotherapy +/- Bevacizumab for Early Stage NSCLC: Updated Chemotherapy Subset Analysis
14:05 - 14:10 | Presenter: Heather A Wakelee | Author(s): Suzanne E Dahlberg, Steven M Keller, William J Tester, Seena C Aisner, Jan M. Rothman, Jyoti D Patel, Robert Delaune, Sean R McDermott, Atif Shafqat, Roman Perez-Soler, Andrew E Chapman, Samer S Kasbari, Anne M Traynor, Tracey L Evans, Leora Horn, Stephen L Graziano, David R Gandara, Alex A Adjei, Charles A Butts, Natasha B Leighl, Suresh S Ramalingam, Joan H Schiller
- Abstract
Loading... -
+
MA06.08 - Discussant - MA06.05, MA06.06, MA06.07
14:10 - 14:20 | Presenter: Jordi Remon
- Abstract
No abstract available for this presentation
-
+
MA06.09 - Timing of Driver Mutation Development and the Genetic Evolution of Semi-Solid Lung Nodules into Early NSCLC
14:20 - 14:25 | Presenter: Gavitt A Woodard | Author(s): Vivianne Ding, Il-Jin Kim, Kirk Jones, Gordon Chavez, Greg Haro, Johannes Kratz, Michael J. Mann, Julia Rotow, Collin M Blakely, David M Jablons
- Abstract
Loading... -
+
MA06.10 - Stereotactic Ablative Radiotherapy in the Management of Synchronous Early Stage Non-Small Cell Lung Cancers
14:25 - 14:30 | Presenter: Zeina Ayoub | Author(s): Eric D Brooks, James W Welsh, Aileen Chen, Saumil Gandhi, John Victor Heymach, Ara A Vaporciyan, Joe Y Chang
- Abstract
Loading... -
+
MA06.12 - Discussant - MA06.09, MA06.10, MA06.11
14:30 - 14:45 | Presenter: Samina Park
- Abstract
No abstract available for this presentation
-
+
MA06.13 - Tsuguo Naruke Lectureship Award for Surgery
14:45 - 14:55 | Presenter: Raja Flores
- Abstract
No abstract available for this presentation
-
+
MA07 - Clinical Questions and Potential Blood Markers for Immunotherapy
- 13:30 - 15:00
- 9/08/2019
- Location: Vancouver (2003)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Immuno-oncology
- Moderators:David R Spigel, Roberto Ferrara
-
+
MA07.01 - Circulating Immature Neutrophils, Tumor-Associated Neutrophils and dNLR for Identification of Fast Progressors to Immunotherapy in NSCLC
13:30 - 13:35 | Presenter: Laura Mezquita | Author(s): Patricia Martin-Romano, Edouard Auclin, Boris Duchemann, Lydie Cassard, David Planchard, Marie Naigeon, Ithar Gataa, Melinda Charrier, Roberto Ferrara, Lisa Boselli, Jonathan Grivel, Maud Ngocamus, Julien Adam, Nathalie Chaput, Benjamin Besse
- Abstract
Loading... -
+
MA07.02 - Early Change of dNLR Is Correlated with Outcomes in Advanced NSCLC Patients Treated with Immunotherapy
13:35 - 13:40 | Presenter: Laura Mezquita | Author(s): Isabel Preeshagul, Edouard Auclin, Diana Saravia, Lizza Hendriks, Hira Rizvi, David Planchard, Wungki Park, Ernest Nadal, Jose Carlos Ruffinelli, Santiago Ponce, Clarisse Audigier-Valette, Simona Carnio, Silvia Novello, Gerard Zalcman, Margarita Majem, Annapaola Mariniello, Anne Marie Clasina Dingemans, Gilberto Lopes, Caroline Rossoni, Jean-Pierre Pignon, Nathalie Chaput, Matthew Hellmann, Kathryn C. Arbour, Benjamin Besse
- Abstract
Loading... -
+
MA07.03 - A Circulating MicroRNAs-Based Test as Biomarker of Primary and Secondary Resistance in PD-L1 ≥50% NSCLC Treated with Immunotherapy
13:40 - 13:45 | Presenter: Claudia Proto | Author(s): Arsela Prelaj, Carla Verri, Diego Signorelli, Giuseppe Lo Russo, Roberto Ferrara, Giulia Galli, Benedetta Trevisan, Mavis Mensah, Filippo Guglielmo Maria De Braud, Marina Chiara Garassino, Gabriella Sozzi, Mattia Boeri
- Abstract
Loading... -
+
MA07.04 - Discussant - MA07.01, MA07.02, MA07.03
13:45 - 14:00 | Presenter: Sara Pilotto
- Abstract
No abstract available for this presentation
-
+
MA07.05 - Immune Checkpoint Inhibitor (ICPi) Re-Challenge: Outcomes Analysis in a French National Cohort of Non-Small-Cell Lung Cancer (NSCLC) Patients
14:00 - 14:05 | Presenter: Elisa Gobbini | Author(s): Anne Claire Toffart, Maurice Perol, Jean-Baptiste Assié, Michael Duruisseaux, Dahna Coupez, Radj Gervais, Virginie Westeel, Myriam Delaunay, Florian Guisier, Remi Veillon, Valérie Gounant, Etienne Giroux Leprieur, François Roger Vanel, Nouha Chaabane, Eric Dansin, Hélène Babey, Chantal Decroisette, Fabrice Barlesi, Nicolas Girard, Pierre Fournel, Laura Mezquita, Youssef Oulkhouir, Anthony Canellas, Boris Duchemann, Olivier Molinier, Denis Moro-Sibilot, Matteo Giaj Levra
- Abstract
Loading... -
+
MA07.06 - Immunotherapy Re-Challenge After Nivolumab Treatment in Advanced Non-Small Cell Lung Cancer in French Real-World Setting
14:05 - 14:10 | Presenter: Matteo Giaj Levra | Author(s): François-Emery Cotté, Romain Corre, Christophe Calvet, Baptiste Jouaneton, Ronan Jolivel, Anne-Françoise Gaudin, Valentine Grumberg, Jean-Baptiste Assié, Christos Chouaid
- Abstract
Loading... -
+
MA07.07 - Discussant - MA07.05, MA07.06
14:10 - 14:25 | Presenter: Helena Linardou
- Abstract
No abstract available for this presentation
-
+
MA07.08 - The Role of a Cachexia Grading System in Patients with NSCLC Treated with Immunotherapy: Implications for Response and Survival
14:25 - 14:30 | Presenter: Jenny Georgina Turcott | Author(s): Andrés Felipe Cardona, Laura Alejandra Ramírez-Tirado, Zyanya Lucia Zatarain Barrón, Feliciano Barrón, Luis Corrales, Claudio Martin, Pablo Alan Barragán Castillo, Diana Flores-Estrada, Alejandro Ruiz-Patiño, Oscar Gerardo Arrieta
- Abstract
Loading... -
+
MA07.09 - Impact of Body Mass Index on Clinical Outcomes of Immune Checkpoint Blockers in Advanced Non-Small Cell Lung Cancer
14:30 - 14:35 | Presenter: Amit Arun Kulkarni | Author(s): Shijia Zhang, Todd De For, Manish Patel
- Abstract
Loading... -
+
MA07.10 - The Influence of Sex on Immunotherapy Efficacy in Non-Small Cell Lung Cancer
14:35 - 14:40 | Presenter: Stephanie Tuminello | Author(s): Rajwanth Veluswamy, Naomi Alpert, John Lazar, Raja Flores, Maaike Van Gerwen
- Abstract
Loading... -
+
MA07.11 - Survival Outcomes Based on Gender of Advanced Nonsmall Cell Lung Cancer Patients Treated with Pembrolizumab or Nivolumab in Everyday Clinical Practice
14:40 - 14:45 | Presenter: Doran Ksienski | Author(s): Elaine S Wai, Nicole Croteau, Ashley T. Freeman, Leathia Fiorino, Angela Chan, Dave Fenton, Georgia Geller, Edward Brooks, Zia Poonja, Sarah Irons, Mary Lesperance
- Abstract
Loading... -
+
MA07.12 - Discussant - MA07.08, MA07.09, MA07.10, MA07.11
14:45 - 15:00 | Presenter: Sonja Loges
- Abstract
No abstract available for this presentation
-
+
MS03 - Workup and Management of Small Anterior Mediastinal Masses/Lesions
- 13:30 - 15:00
- 9/08/2019
- Location: Amsterdam (2011)
- IASLC CME Accredited
- Type: Mini Symposium
- Track: Thymoma/Other Thoracic Malignancies
- Moderators:Meinoshin Okumura, Pier Luigi Filosso
-
+
Introduction/Poll
13:30 - 13:30
- Abstract
No abstract available for this presentation
-
+
MS03.01 - Differentiation of Small Anterior Mediastinal Lesions Using Imaging
13:30 - 13:45 | Presenter: Edith Michelle Marom
- Abstract
Loading... -
+
MS03.02 - Resection, Biopsy or Observation of Small Anterior Mediastinal Lesions
13:45 - 14:00 | Presenter: Frank Detterbeck
- Abstract
Loading... -
+
MS03.03 - Minimally Invasive Surgical Strategies and Considerations for Small Anterior Mediastinal Lesions
14:00 - 14:15 | Presenter: Benny Weksler
- Abstract
Loading... -
+
MS03.04 - Followup/Surveillance of Small Anterior Mediastinal Lesions
14:15 - 14:30 | Presenter: Wentao Fang
- Abstract
Loading... -
+
MS03.05 - Relevance of Nodal Involvement and the Thymic Lymph Node Map
14:30 - 14:45 | Presenter: Jhingook Kim
- Abstract
Loading... -
+
MS03.06 - Q&A/Poll
14:45 - 15:00
- Abstract
No abstract available for this presentation